These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9246677)

  • 21. In vivo modulation of G proteins and opioid receptor function by antisense oligodeoxynucleotides.
    Garzón J; de Antonio I; Sánchez-Blázquez P
    Methods Enzymol; 2000; 314():3-20. PubMed ID: 10565001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine as a novel anti-migration factor of vascular smooth muscle cells through D1A and D1B receptors.
    Yasunari K; Maeda K; Nakamura M; Yoshikawa J
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S33-8. PubMed ID: 12688394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense oligonucleotides as therapeutic agents.
    Alama A; Barbieri F; Cagnoli M; Schettini G
    Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of microtubule-associated protein 1B expression by antisense oligodeoxynucleotides inhibits initiation of neurite outgrowth.
    Brugg B; Reddy D; Matus A
    Neuroscience; 1993 Feb; 52(3):489-96. PubMed ID: 8450955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment with antisense oligodeoxynucleotides directed against the NMDA-R1 receptor enhances survival and behavioral recovery following traumatic brain injury in rats.
    Sun FY; Faden AI
    Brain Res; 1995 Sep; 693(1-2):163-8. PubMed ID: 8653404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense approaches to cancer gene therapy.
    Mercola D; Cohen JS
    Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotides induce functional deletion of ligand gated ion channels in cultured neurons and brain explants.
    Brussaard AB
    J Neurosci Methods; 1997 Jan; 71(1):55-64. PubMed ID: 9125375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides.
    Silvia CP; Jaber M; King GR; Ellinwood EH; Caron MG
    Neuroscience; 1997 Feb; 76(3):737-47. PubMed ID: 9135047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enduring consequences of neonatal treatment with antisense oligodeoxynucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain.
    McCarthy MM; Schlenker EH; Pfaff DW
    Endocrinology; 1993 Aug; 133(2):433-9. PubMed ID: 8344188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced level of calmodulin in PC12 cells induced by stable expression of calmodulin antisense RNA inhibits cell proliferation and induces neurite outgrowth.
    Davidkova G; Zhang SP; Nichols RA; Weiss B
    Neuroscience; 1996 Dec; 75(4):1003-19. PubMed ID: 8938737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
    Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
    DeMoor JM; Vincent MD; Collins OM; Koropatnick J
    Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interruption of a transforming growth factor alpha autocrine loop in Caco-2 cells by antisense oligodeoxynucleotides.
    Bishop WP; Lin J; Stein CA; Krieg AM
    Gastroenterology; 1995 Dec; 109(6):1882-9. PubMed ID: 7498653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense strategies: functions and applications in immunology.
    Varga LV; Tóth S; Novák I; Falus A
    Immunol Lett; 1999 Aug; 69(2):217-24. PubMed ID: 10482355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides.
    Miayake H; Tolcher A; Gleave ME
    J Natl Cancer Inst; 2000 Jan; 92(1):34-41. PubMed ID: 10620631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.
    Agrawal S
    Biochim Biophys Acta; 1999 Dec; 1489(1):53-68. PubMed ID: 10806997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of endomorphin-1 and endomorphin-2 binding sites in human mu-opioid receptor by antisense oligonucleotide strategy.
    Fichna J; Gach K; Perlikowska R; Poels J; Vanden Broeck J; Szemraj J; Janecka A
    Chem Biol Drug Des; 2008 Dec; 72(6):507-12. PubMed ID: 19090917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introducing antisense oligodeoxynucleotides into Paramecium via electroporation.
    Fraga D; Yano J; Reed MW; Chuang R; Bell W; Van Houten JL; Hinrichsen R
    J Eukaryot Microbiol; 1998; 45(6):582-8. PubMed ID: 9864848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense oligonucleotides for central nervous system tumors.
    Hall WA; Flores EP; Low WC
    Neurosurgery; 1996 Feb; 38(2):376-83. PubMed ID: 8869067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.